Table 1: General andbiochemical features of individuals participated in the study.

 

HC

PD

Gr A

Gr B

Gr C

Gr D

GrT

P

HbA1c Level (%)

HbA1c < 5.7

5.7 ≤ HbA1c ≤ 6.4 IFG/IGT. IFG + IGT

HbA1c ≤ 6.4

6.5 ≤ HbA1c ≤ 7.9

8.0 ≤ HbA1c ≤ 9.9

10.0 ≤ HbA1c

 

 

Number

24 (%14.2)

28 (%16.5)

29 (%17.1)

30 (%17.7)

29 (%17.1)

29 (%17.1)

169

-

Gender (M/F)

 13/11

15/13

15/14

16/14

14/15

15/14

88/81

-

Age (year)

47.9 ± 5.75

52.1 ± 8.63

58.1 ± 9.22

56.2 ± 9.55

56.0 ± 7.60

57.1 ± 8.89

54.8 ± 8.98

0.001

BMI (kg/m2)

27.2 ± 3.11

32.1 ± 5.77

32.8 ± 5.47

33.8 ± 5.51

34.8 ± 5.25

35.6 ± 5.85

32.9 ± 5.83

0.001

WHR (cm)*

0.92 ± 0.07

0.96 ± 0.04

0.98 ± 0.59

0.98 ± 0.06

0.97 ± 0.06

1.00 ± 0.05

0.97 ± 0.06

0.001

HbA1c (NGSP) (%)

5.09 ± 0.17

5.73 ± 0.45

5.87 ± 0.34

7.01 ± 0.45

8.86 ± 0.65

11.31 ± 1.14

7.39 ± 2.24

0.001

FBG (mg/dl)

84 ± 5.4

103 ± 8.7

116 ± 17.3

138 ± 17.7

182 ± 40.1

264 ± 54.4

150 ± 67.4

0.001

PPG (mg/dl)

88 ± 10.5

123 ± 30.7

131 ± 41.0

197 ± 44.2

248 ± 76.5

327 ± 117.8

190 ± 103.5

0.001

FI (μU/ml)

7.9 ± 4.4

14.4 ± 7.3

15.0 ± 8.1

17.9 ± 10.5

16.1 ± 14.6

13.9 ± 8.4

14.4 ± 9.9

0.001

HOMA-IR index

1.65 ± 0.92

3.72 ± 2.15

4.38 ± 2.36

6.29 ± 3.77

7.45 ± 9.46

9.06 ± 6.05

5.60 ± 5.65

0.001

FCP (ng/ml)

1.36 ± 0.52

2.38 ± 0.69

2.26 ± 0.92

2.46 ± 1.17

2.12 ± 1.24

2.15 ± 1.28

2.15 ± 1.07

0.001

CRP (mg/l)

2.0 ± 0.24

2.8 ± 2.4

3.0 ± 2.2

3.8 ± 2.2

5.7 ± 4.4

8.3 ± 8.8

4.3 ± 4.8

0.001

UA (mg/dl)

4.5 ± 0.9

5.2 ± 1.5

5.5 ± 1.2

5.1 ± 2

4.6 ± 1.7

4.1 ± 1.4

4.8 ± 1.6

0.002

Crn (mg/dl)

0.76 ± 0.15

0.82 ± 0.17

0.72 ± 0.14

0.76 ± 0.18

0.71 ± 0.17

0.70 ± 0.19

0.74 ± 0.17

0.102

MAU (mg)

5.95 ± 4.09

17.8 ± 56.4

29.8 ± 57.1

46.8 ± 65.9

65.6 ± 94.4

53.4 ± 88.2

37.8 ± 70.8

0.001

Tcol (mg/dl)*

176 ± 41

188 ± 36

195 ± 39

212 ± 53

193 ± 43

192 ± 34

193 ± 2

0.072

HDL-c (mg/dl)

51 ± 14

42 ± 9

42 ± 7

43 ± 9

40 ± 10

39 ± 10

43 ± 10

0.009

LDL-c (mg/dl)

93 ± 40

110 ± 34

117 ± 30

132 ± 48

95 ± 44

90 ± 47

107 ± 43

0.014

TG (mg/dl)

123 ± 108

168 ± 97

169 ± 81

211 ± 130

297 ± 523

295 ± 306

214 ± 270

0.001

TAC (mmol Trolox eq.)

0.75 ± 0.07

0.67 ± 0.07

0.65 ± 0.08

0.70 ± 0.07

0.65 ± 0.08

0.70 ± 0.06

 0.68 ± 0.08

0.001

TOS (μmol H2O2 )

23.2 ± 2.4

26 ± 4.3

25.6 ± 0.6

27.1 ± 4.4

26.8 ± 5.3

27.7 ± 4.5

26.2 ± 4.4

0.004

OSI

31 ± 5.2

39.3 ± 7.2

39.7 ± 8

39.3 ± 8.7

41.9 ± 11.5

39.8 ± 7.8

38.7 ± 8.9

0.001

HC: Healthy Control; PD: Prediabet; Gr A: Group A ; Gr B: Group B; Gr C: Group C; Gr D: Group D; Gr T: Group Total; BMI: Body Mass Index; WHR: Waist-Hip Ratio; HbA1c: Glycosilated hemoglobin; FBG: Fasting Blood Glucose; PPG: Post Prandial Glucose; FI: Fasting Insulin; HOMA-IR: Homeostatic Model of Assessment-Insulin Resistance; FCP: Fasting C-Peptide; CRP: C-Reactive Protein; Crn: Creatinine; UA: Uric Acid; MAU: Microalbuminuria; T col: Total Cholesterol; HDL-c: High-Density Lipoprotein; LDL-c: Low-Density Lipoprotein; TG: Triglyceride; TAC: Total Antioxidant Capacity; TOS: Total Oxidative State; OSI: Oxidative Stress Index Data : Were expressed as mean ± SD; p values (*) oneway ANOVA. other data were calculated by Kruskal Walls tests